Compare GIFI & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GIFI | SGMO |
|---|---|---|
| Founded | 1985 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 191.0M | 155.1M |
| IPO Year | 1997 | 2000 |
| Metric | GIFI | SGMO |
|---|---|---|
| Price | $11.96 | $0.44 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $5.60 |
| AVG Volume (30 Days) | 169.0K | ★ 4.3M |
| Earning Date | 11-12-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.55 | N/A |
| Revenue | ★ $166,767,000.00 | $32,875,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $21.66 | ★ N/A |
| Revenue Growth | ★ 0.26 | N/A |
| 52 Week Low | $5.75 | $0.38 |
| 52 Week High | $12.00 | $1.51 |
| Indicator | GIFI | SGMO |
|---|---|---|
| Relative Strength Index (RSI) | 87.10 | 47.52 |
| Support Level | $11.92 | $0.40 |
| Resistance Level | $11.98 | $0.44 |
| Average True Range (ATR) | 0.02 | 0.03 |
| MACD | -0.08 | 0.00 |
| Stochastic Oscillator | 55.56 | 44.80 |
Gulf Island Fabrication Inc is a U.S. based company that is a fabricator of complex steel structures and marine vessels. The company also provides installation, hook-up, commissioning, repair, and maintenance services with specialized crews. The company operates through segments namely Fabrication division which fabricates structures such as offshore drilling and production platforms and other steel structures for customers in the oil and gas industries; the Shipyards division manufactures newly built and repairs various steel marine vessels in the United States; the Services division provides interconnect piping services on offshore platforms, welding, and inshore structures and also provides maintenance and industrial facilities. Majority revenue is from services segment.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.